# Arrow Financial Corp: financial statements, quarterly

AROW · Nasdaq · CIK 717538 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arow.md) · [Financials](/companies/arow/financials.md) · [Filings](/companies/arow/filings.md) · [Insiders](/companies/arow/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arow/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [16.8](/filings/0000717538-24-000116.md) | [18.7 d](/filings/0000717538-26-000037.md) | [20.2](/filings/0000717538-25-000056.md) | [20.8](/filings/0000717538-25-000079.md) | [21.0](/filings/0000717538-25-000102.md) | [21.2 d](/filings/0000717538-26-000037.md) | [19.0](/filings/0000717538-26-000060.md) | [19.0](/filings/0000717538-26-000117.md) | [19.5](/filings/0000717538-25-000102.md) | [19.5 d](/filings/0000717538-26-000037.md) | [17.7](/filings/0000717538-26-000060.md) | [17.7](/filings/0000717538-26-000117.md) |
| Income tax | $m | [1.8](/filings/0000717538-24-000116.md) | [1.7 d](/filings/0000717538-26-000037.md) | [2.0](/filings/0000717538-25-000056.md) | [2.3](/filings/0000717538-25-000079.md) | [2.6](/filings/0000717538-25-000102.md) | [0.8 d](/filings/0000717538-26-000037.md) | [1.8](/filings/0000717538-26-000060.md) | [3.1](/filings/0000717538-26-000117.md) | [3.8](/filings/0000717538-25-000102.md) | [2.7 d](/filings/0000717538-26-000037.md) | [3.9](/filings/0000717538-26-000060.md) | [2.9](/filings/0000717538-26-000117.md) |
| Net income | $m | [7.7](/filings/0000717538-24-000116.md) | [7.7 d](/filings/0000717538-26-000037.md) | [7.7](/filings/0000717538-25-000056.md) | [8.6](/filings/0000717538-25-000079.md) | [9.0](/filings/0000717538-25-000102.md) | [4.5 d](/filings/0000717538-26-000037.md) | [6.3](/filings/0000717538-26-000060.md) | [10.8](/filings/0000717538-26-000117.md) | [12.8](/filings/0000717538-25-000102.md) | [14.0 d](/filings/0000717538-26-000037.md) | [13.5](/filings/0000717538-26-000060.md) | [11.0](/filings/0000717538-26-000117.md) |
| Diluted EPS | $ per share | [0.46](/filings/0000717538-24-000116.md) | not reported | [0.45](/filings/0000717538-25-000056.md) | [0.52](/filings/0000717538-25-000079.md) | [0.53](/filings/0000717538-25-000102.md) | not reported | [0.38](/filings/0000717538-26-000060.md) | [0.65](/filings/0000717538-26-000117.md) | [0.77](/filings/0000717538-25-000102.md) | not reported | [0.82](/filings/0000717538-26-000060.md) | [0.66](/filings/0000717538-26-000117.md) |
| Basic EPS | $ per share | [0.46](/filings/0000717538-24-000116.md) | not reported | [0.45](/filings/0000717538-25-000056.md) | [0.52](/filings/0000717538-25-000079.md) | [0.54](/filings/0000717538-25-000102.md) | not reported | [0.38](/filings/0000717538-26-000060.md) | [0.65](/filings/0000717538-26-000117.md) | [0.77](/filings/0000717538-25-000102.md) | not reported | [0.82](/filings/0000717538-26-000060.md) | [0.66](/filings/0000717538-26-000117.md) |

- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [4,273](/filings/0000717538-24-000116.md) | [4,170](/filings/0000717538-25-000023.md) | [4,334](/filings/0000717538-24-000076.md) | [4,244](/filings/0000717538-24-000100.md) | [4,411](/filings/0000717538-24-000116.md) | [4,306](/filings/0000717538-26-000037.md) | [4,449](/filings/0000717538-25-000056.md) | [4,415](/filings/0000717538-25-000079.md) | [4,587](/filings/0000717538-25-000102.md) | [4,446](/filings/0000717538-26-000117.md) | [4,522](/filings/0000717538-26-000060.md) | [4,482](/filings/0000717538-26-000117.md) |
| Total liabilities | $m | [3,913](/filings/0000717538-24-000116.md) | [3,790](/filings/0000717538-25-000023.md) | [3,956](/filings/0000717538-24-000076.md) | [3,861](/filings/0000717538-24-000100.md) | [4,018](/filings/0000717538-24-000116.md) | [3,905](/filings/0000717538-26-000037.md) | [4,044](/filings/0000717538-25-000056.md) | [4,006](/filings/0000717538-25-000079.md) | [4,169](/filings/0000717538-25-000102.md) | [4,014](/filings/0000717538-26-000117.md) | [4,082](/filings/0000717538-26-000060.md) | [4,036](/filings/0000717538-26-000117.md) |
| Long-term debt | $m | not reported | [6.5](/filings/0000717538-25-000023.md) | not reported | not reported | not reported | [8.6](/filings/0000717538-26-000037.md) | not reported | not reported | not reported | [4.3](/filings/0000717538-26-000037.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | [26.5](/filings/0000717538-25-000023.md) | not reported | not reported | not reported | [8.6](/filings/0000717538-26-000037.md) | not reported | [8.6](/filings/0000717538-25-000079.md) | [4.3](/filings/0000717538-25-000102.md) | [4.3](/filings/0000717538-26-000117.md) | [4.3](/filings/0000717538-26-000060.md) | [310](/filings/0000717538-26-000117.md) |
| Shareholders' equity | $m | [360](/filings/0000717538-24-000116.md) | [380](/filings/0000717538-26-000037.md) | [378](/filings/0000717538-25-000079.md) | [383](/filings/0000717538-25-000102.md) | [393](/filings/0000717538-25-000102.md) | [401](/filings/0000717538-26-000117.md) | [404](/filings/0000717538-26-000117.md) | [409](/filings/0000717538-26-000117.md) | [418](/filings/0000717538-25-000102.md) | [432](/filings/0000717538-26-000117.md) | [440](/filings/0000717538-26-000117.md) | [446](/filings/0000717538-26-000117.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.2 d](/filings/0000717538-24-000116.md) | [(16.3) d](/filings/0000717538-26-000037.md) | [10.3](/filings/0000717538-25-000056.md) | [9.1 d](/filings/0000717538-25-000079.md) | [9.4 d](/filings/0000717538-25-000102.md) | [5.6 d](/filings/0000717538-26-000037.md) | [10.1](/filings/0000717538-26-000060.md) | [10.3 d](/filings/0000717538-26-000117.md) | [15.0 d](/filings/0000717538-25-000102.md) | [5.9 d](/filings/0000717538-26-000037.md) | [15.2](/filings/0000717538-26-000060.md) | [15.8 d](/filings/0000717538-26-000117.md) |
| Capital expenditure | $m | [1.4 d](/filings/0000717538-24-000116.md) | [0.6 d](/filings/0000717538-26-000037.md) | [1.2](/filings/0000717538-25-000056.md) | [1.6 d](/filings/0000717538-25-000079.md) | [1.4 d](/filings/0000717538-25-000102.md) | [1.5 d](/filings/0000717538-26-000037.md) | [1.3](/filings/0000717538-26-000060.md) | [2.0 d](/filings/0000717538-26-000117.md) | [0.7 d](/filings/0000717538-25-000102.md) | [1.1 d](/filings/0000717538-26-000037.md) | [1.3](/filings/0000717538-26-000060.md) | [4.2 d](/filings/0000717538-26-000117.md) |
| Share repurchases | $m | [0.0 d](/filings/0000717538-24-000116.md) | [2.8 d](/filings/0000717538-26-000037.md) | [6.0](/filings/0000717538-25-000056.md) | [0.5 d](/filings/0000717538-25-000079.md) | [0.1 d](/filings/0000717538-25-000102.md) | [0.3 d](/filings/0000717538-26-000037.md) | [3.5](/filings/0000717538-26-000060.md) | [5.2 d](/filings/0000717538-26-000117.md) | [1.4 d](/filings/0000717538-25-000102.md) | [0.2 d](/filings/0000717538-26-000037.md) | [0.1](/filings/0000717538-26-000060.md) | [0.4 d](/filings/0000717538-26-000117.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.1](/filings/0000717538-23-000239.md) | [17.1](/filings/0000717538-24-000076.md) | [17.1](/filings/0000717538-24-000100.md) | [17.1](/filings/0000717538-24-000116.md) | [16.9](/filings/0000717538-25-000056.md) | [16.7](/filings/0000717538-25-000079.md) | [16.7](/filings/0000717538-25-000102.md) | [16.7](/filings/0000717538-26-000060.md) | [16.6](/filings/0000717538-26-000117.md) | [16.4](/filings/0000717538-25-000102.md) | [16.4](/filings/0000717538-26-000060.md) | [16.5](/filings/0000717538-26-000117.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,523,723 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000717538-26-000117.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.